Changes in Intestinal Microbiota Tracked Using Next-generation Sequencing Before and after Antimicrobial Administration: An Example of Short-bowel Syndrome
Abstract
Although patients with short bowel syndrome may receive antimicrobial therapy for complications associated with abnormal intestinal microbiota, no established criteria for target bacterial screening or antimicrobial susceptibility standards exist. As a result, antimicrobial therapy is often administered without a microbiological evaluation. However, this approach carries uncertainties and risks, as antimicrobials can alter the microbiota in undesirable ways. To address this issue, we administered antimicrobial therapy to a patient with short bowel syndrome associated with chronic metabolic acidosis and monitored the changes in the intestinal microbiota using next-generation sequencing. We report these findings as they provide new insights into short bowel syndrome.
Related
- Postelectroacupuncture Fecal Microbiota Transplantation (post‐EA FMT) Regulates Gastrointestinal Hormones in Functional Dyspepsia Rats Is Associated With Modulation of the Intestinal Microbiota‐Bile Acid Metabolic Pathway
- Gut microbiota-bone marrow axis: how intestinal signals remodel hematopoiesis and immune status
- Gut microbiota and intestinal permeability in rheumatoid arthritis: therapeutic implications and future directions
- Identification of Survival-Associated miRNA Signatures in Glioblastoma Using Next-Generation Sequencing
- Plant-derived extracellular vesicles for intestinal mucosal repair: mechanisms, microbiota-host interactions, and bioengineered delivery
BibTeX
@article{hasumi2026changes,
title = {{Changes in Intestinal Microbiota Tracked Using Next-generation Sequencing Before and after Antimicrobial Administration: An Example of Short-bowel Syndrome}},
author = {Jumpei Hasumi and Gaku Harata},
journal = {Internal Medicine},
year = {2026},
month = aug,
doi = {10.2169/internalmedicine.6890-25},
url = {https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_6890-25/_article},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Changes in Intestinal Microbiota Tracked Using Next-generation Sequencing Before and after Antimicrobial Administration: An Example of Short-bowel Syndrome
AU - Jumpei Hasumi
AU - Gaku Harata
PY - 2026
DA - 2026/08/25
JO - Internal Medicine
DO - 10.2169/internalmedicine.6890-25
UR - https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_6890-25/_article
AB - Although patients with short bowel syndrome may receive antimicrobial therapy for complications associated with abnormal intestinal microbiota, no established criteria for target bacterial screening or antimicrobial susceptibility standards exist. As a result, antimicrobial therapy is often administered without a microbiological evaluation. However, this approach carries uncertainties and risks, as antimicrobials can alter the microbiota in undesirable ways. To address this issue, we administered antimicrobial therapy to a patient with short bowel syndrome associated with chronic metabolic acidosis and monitored the changes in the intestinal microbiota using next-generation sequencing. We report these findings as they provide new insights into short bowel syndrome.
SN - 1349-7235
SN - 0918-2918
ER -